Introduction: FOXO4-DRI peptide permits selective apoptosis of senescent cells, supports metabolic studies, and ensures security in analysis, improving reproducibility and advancing getting older and oncology investigations. every day laboratory workflows typically expose gaps exactly where current compounds fall short to deal with cell senescence